Literature DB >> 8596049

Identification of an N-terminally truncated form of the chemokine RANTES and granulocyte-macrophage colony-stimulating factor as major eosinophil attractants released by cytokine-stimulated dermal fibroblasts.

N Noso1, M Sticherling, J Bartels, A I Mallet, E Christophers, J M Schröder.   

Abstract

Eosinophil (Eo) granule proteins and, rarely, intact Eos represent a characteristic histopathologic feature of the dermal part of affected tissue in atopic dermatitis and some allergic reactions. Dermal fibroblasts are a rich source of cytokines and inflammatory mediators; therefore, we have investigated whether these cells release Eo chemoattractants when stimulated with different stimuli. Eo-chemotactic activity was detected after stimulation of cells with TNF-alpha and IL-1, but not when phorbol ester, PHA, or medium alone was used. Biochemical characterization of Eo-chemotactic activity in supernatants of NF-alpha-stimulated cells revealed both heparin-binding and nonbinding activity. HPLC purification with subsequent N-terminal sequencing and mass spectrometric analysis showed that the heparin-binding Eo-chemotactic peak corresponded to the chemokine [Tyr-RANTES]66 that also contained [Ser-RANTES]68 as contaminant, whereas the nonheparin-binding activity was identified as granulocyte-macrophage CSF (GM-CSF) by the use of neutralizing Abs. [Tyr-RANTES]66 was found to show identical behavior in the chemotaxis assay system with respect to potency and efficacy as natural [Ser-RANTES]68. These findings support the hypothesis that dermal fibroblasts can play an important role in the recruitment of Eo by release of the chemokine RANTES together with GM-CSF.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8596049

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Isolation and purification of chemokines from natural sources.

Authors:  J M Schröder
Journal:  Mol Biotechnol       Date:  2001-05       Impact factor: 2.695

2.  Erythromycin modulates eosinophil chemotactic cytokine production by human lung fibroblasts in vitro.

Authors:  E Sato; D K Nelson; S Koyama; J C Hoyt; R A Robbins
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

3.  Increased levels in vivo of mRNAs for IL-8 and macrophage inflammatory protein-1 alpha (MIP-1 alpha), but not of RANTES mRNA in peripheral blood mononuclear cells of patients with atopic dermatitis (AD).

Authors:  Y Hatano; K Katagiri; S Takayasu
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

4.  Modulation of RANTES production by human cytomegalovirus infection of fibroblasts.

Authors:  S Michelson; P Dal Monte; D Zipeto; B Bodaghi; L Laurent; E Oberlin; F Arenzana-Seisdedos; J L Virelizier; M P Landini
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

5.  Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage.

Authors:  T Oravecz; M Pall; G Roderiquez; M D Gorrell; M Ditto; N Y Nguyen; R Boykins; E Unsworth; M A Norcross
Journal:  J Exp Med       Date:  1997-12-01       Impact factor: 14.307

Review 6.  Regulation of Chemokine Activity - A Focus on the Role of Dipeptidyl Peptidase IV/CD26.

Authors:  Mieke Metzemaekers; Jo Van Damme; Anneleen Mortier; Paul Proost
Journal:  Front Immunol       Date:  2016-11-11       Impact factor: 7.561

Review 7.  CD26/dipeptidylpeptidase IV-chemokine interactions: double-edged regulation of inflammation and tumor biology.

Authors:  Anneleen Mortier; Mieke Gouwy; Jo Van Damme; Paul Proost; Sofie Struyf
Journal:  J Leukoc Biol       Date:  2016-01-07       Impact factor: 4.962

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.